Molecular subtype analysis indicated that high expression of DCN in malignant epithelial cells is a predictor of decreased OS (HR: 2.33 vs. low expression p = 0.002) only in luminal B subtype tumours (Figure 5) as is high expression of DCN in the benign peri-lesional stroma (data not shown). This evidence concerns the gene DCN and neoplasm.